Hospital Quirónsalud Valencia

Valencia, València 46010

0 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Neoplasm Metastasis

Studies at this site

• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling
• A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer — Running, not enrolling